Dublin, July 13, 2023 (GLOBE NEWSWIRE) -- The "Global Idiopathic Pulmonary Fibrosis (IPF) Market (2023 Edition): Analysis By Drug Type (Pirfenidone, Nintedanib, Others), Route of Administration (Oral, Parenteral, Others), Distribution Channel, By Region, By Country: Market Insights and Forecast (2019-2029)" report has been added to ResearchAndMarkets.com's offering.
The global market for idiopathic pulmonary fibrosis (IPF) is experiencing significant growth. This recent market analysis report provides valuable insights into the IPF market, including historical data, current trends, and future projections.
The report thoroughly analyzes the IPF market based on its value in USD million. It covers the historical period of 2018-2022, estimates the market conditions for [Current Year], and provides a forecast for the period of 2024-2029. This comprehensive analysis offers a comprehensive understanding of the market dynamics and helps stakeholders make informed decisions.
The analysis further categorizes the IPF market based on drug type, including Pirfenidone, Nintedanib, and other drugs. It also examines the market based on the route of administration, such as oral, parenteral, and other routes. Additionally, the report explores the distribution channels for IPF products, including hospital pharmacies, retail pharmacies, and the online channel.
The global IPF market analysis extends to multiple countries, including the United States, Canada, the United Kingdom, Germany, France, Italy, Spain, China, South Korea, India, and Japan. By analyzing market trends and opportunities across these regions, the report offers valuable insights into regional dynamics and potential growth areas.
Using frameworks such as SWOT analysis and Porter's Five Forces Analysis, the report presents key insights and evaluates the market's attractiveness. It also examines the major opportunities, trends, drivers, and challenges in the industry. This information helps stakeholders gain a comprehensive understanding of the market landscape and make strategic decisions.
The report tracks competitive developments in the IPF market, including strategies, mergers and acquisitions, and new product developments. Key players analyzed in the report include Boehringer Ingelheim, F. Hoffmann-La Roche AG, Cipla Ltd., Shionogi & Co., Ltd., Bristol-Myers Squibb Co., United Therapeutics, FibroGen, Inc., Pliant Therapeutics, Galecto Inc., and CSL Behring. Their contributions to the IPF market are examined, providing valuable insights into the competitive landscape and future market trends.
As the prevalence of idiopathic pulmonary fibrosis continues to rise, this market analysis report serves as a valuable resource for healthcare professionals, researchers, and industry stakeholders. It offers a comprehensive overview of the market, empowering decision-makers to navigate the evolving landscape of IPF treatment and contribute to better patient outcomes.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 260 |
| Forecast Period | 2024 - 2029 |
| Estimated Market Value (USD) in 2024 | $5.9 Billion |
| Forecasted Market Value (USD) by 2029 | $10.6 Billion |
| Compound Annual Growth Rate | 12.6% |
| Regions Covered | Global |
Key Topics Covered:
1. Market Background
2. Strategic Recommendations
3. Global Idiopathic Pulmonary Fibrosis Market: Historic and Forecast (2018-2028)
4. Global Idiopathic Pulmonary Fibrosis Market, Regional Analysis
5. Americas Idiopathic Pulmonary Fibrosis Market: Historic and Forecast (2018-2028)
6. Europe Idiopathic Pulmonary Fibrosis Market: Historic and Forecast (2018-2028)
7. Asia-Pacific Idiopathic Pulmonary Fibrosis Market: Historic and Forecast (2018-2028)
8. Middle-East & Africa Idiopathic Pulmonary Fibrosis Market: Historic and Forecast (2018-2028)
9. Market Dynamics
10. Industry Ecosystem Analysis
11. Competitive Positioning
For more information about this report visit https://www.researchandmarkets.com/r/md97qm
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
